Back to AVTX

Caligan Partners LP → AVTX

Caligan Partners LP AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$50.1M
Q3 2026
Peak value
$58.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16M
Q1 2026$24.4M
Q2 2026$58.5M
Q3 2026$50.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$50.1M3.27M——
Q2 2026$58.5M3.16M——
Q1 2026$24.4M1.64M——
Q4 2025$16M881.5K——

Other funds holding AVTX

Other Caligan Partners LP positions

LQDA

LIQUIDIA CORPORATION

$647.3M
RVMDW

REVOLUTION MEDICINES INC

$402.7M
RVMDW

REVOLUTION MEDICINES INC

$367.4M
LQDA

LIQUIDIA CORPORATION

$306.4M
LQDA

LIQUIDIA CORPORATION

$280M
LQDA

LIQUIDIA CORPORATION

$245.7M
AAVXF

ABIVAX SA

$207.6M
AAVXF

ABIVAX SA

$195.8M